US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Gilead Sciences

106.38

+0.87000.82%

Post-market: 107.000.6200+0.58%17:29 EDT

Volume:7.77M

Turnover:823.47M

Market Cap:132.62B

PE:279.95

High:106.64

Open:105.95

Low:99.32

Close:105.51

Loading ...

Overview Company News Filings

Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag

Citi “Very Bullish” on Gilead’s (NASDAQ:GILD) HIV Business

Are Medical Stocks Lagging Gilead Sciences (GILD) This Year?

SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study

UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study

Gilead Sciences: Using Lessons From the HIV Epidemic To Help Reduce Stigma Around Lung Cancer

ACCESS Newswire

Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy

OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek

Trump Trade: President to sign EO on DOE, weighing Chevron license extension

Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?

The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics

Incyte Had a Bad Week. Investors Are Used to It. -- Barrons.com

Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights

Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More

IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success

Trump Trade: Reciprocal tariffs still to start on April 2

Novartis Reports Updated Positive Data From Phase III SMA Program

Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet

Company News for Mar 20, 2025

Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/GILD/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"GILD","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"Gilead Sciences","latestPrice":106.38,"timestamp":1745438400000,"preClose":105.51,"halted":0,"volume":7767840,"hourTrading":{"tag":"盘后","latestPrice":107,"preClose":106.38,"latestTime":"17:29 EDT","volume":179387,"amount":19083495.81177,"timestamp":1745443753513},"delay":0,"floatShares":1243965050,"shares":1246634469,"eps":0.38,"marketStatus":"Post-Mkt","change":0.87,"latestTime":"04-23 17:32:21 EDT","open":105.95,"high":106.635,"low":99.32,"amount":823470427.3248,"amplitude":0.06933,"askPrice":108.24,"askSize":50,"bidPrice":106.35,"bidSize":5,"shortable":3,"etf":0,"ttmEps":0.38,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1745452800000},"marketStatusCode":4,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":105.51,"dividendRate":0.028953,"preHourTrading":{"tag":"盘前","latestPrice":106.15,"preClose":105.51,"latestTime":"09:28 EDT","volume":4430,"amount":468265.9291,"timestamp":1745414880031},"postHourTrading":{"tag":"盘后","latestPrice":107,"preClose":106.38,"latestTime":"17:29 EDT","volume":179387,"amount":19083495.81177,"timestamp":1745443753513},"volumeRatio":1.049089,"optionData":{"bulkOrders":[{"symbol":"GILD","call":false,"expireDate":1747368000000,"strike":"80.0","timestamp":1745430169395,"price":0.2,"volume":1570,"amount":31400,"type":"+"}]},"impliedVol":0.4002,"impliedVolPercentile":0.94},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"GILD\",,,,,undefined,":{"symbol":"GILD","floatShares":1243965050,"roa":"11.03%","roe":"2.29%","lyrEps":0.384923,"volumeRatio":1.049089,"shares":1246634469,"dividePrice":3.08,"high":106.635,"amplitude":0.06933,"preClose":105.51,"low":99.32,"week52Low":62.07,"pbRate":"6.86","psRate":"4.61","week52High":119.96,"institutionHeld":0.7997,"latestPrice":106.38,"committee":-0.818182,"eps":0.38,"divideRate":0.028953,"volume":7767840,"delay":0,"ttmEps":0.38,"open":105.95,"prevYearClose":92.37,"prevWeekClose":104.54,"prevMonthClose":112.05,"prevQuarterClose":112.05,"fiveDayClose":105.68,"twentyDayClose":107.89,"sixtyDayClose":95.35},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"GILD\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2522056336","title":"Sanofi's Chlamydia Vaccine Candidate Gets FDA's Fast Track Tag","url":"https://stock-news.laohu8.com/highlight/detail?id=2522056336","media":"Zacks","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522056336?lang=en_us&edition=fundamental","pubTime":"2025-03-26 23:53","pubTimestamp":1743004380,"startTime":"0","endTime":"0","summary":"Sanofi SNY announced that the FDA has granted a fast-track designation to its mRNA vaccine candidate for the prevention of chlamydia infection.The company plans to begin a phase I/II study soon, which will evaluate the immunogenicity and safety of the vaccine candidate in adults aged between 18 and 29 years.Sanofi decided to begin the phase I/II study after the chlamydia vaccine candidate demonstrated promising results in pre-clinical studies.Caused by the bacteriumChlamydia trachomatis,chlamydia is a common bacterial infection of the reproductive tract that can lead to infertility and pregnancy complications.The vaccine candidate is being developed to protect against primary genital tract infection and reinfection by the bacterium.In the past 60 days, estimates for Krystal Biotech’s earnings per share have increased from $5.50 to $7.06 for 2025. During the same time, earnings per share estimates for 2026 have increased from $9.15 to $11. Year to date, shares of KRYS have rallied 22.8%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sanofis-chlamydia-vaccine-candidate-gets-155300129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1430594728.SGD","BK4567","LU1585245621.USD","LU0889565916.HKD","SNY","LU0058720904.USD","BK4588","LU2087621335.USD","BK4532","BK4568","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","LU0234570918.USD","IE00B19Z3581.USD","LU0289739699.SGD","IE00BFXG1179.USD","LU0109394709.USD","GILD","IE00BZ1G4Q59.USD","LU2089984988.USD","BK4104","LU1571399168.USD","BK4585","IE00BFXG0V08.USD","LU1066053197.SGD","IE00B3T34201.USD","IE00B5TLWC47.USD","BK4566","IE00BYQQ9H92.USD","KRYS","SNYNF","IE0002270589.USD","LU1839511570.USD","FAST","IE00BKVL7J92.USD","BK4007","BK4578","IE00B7SZLL34.SGD","BK4550","LU2468319806.SGD","LU0320765992.SGD","BK4139","BK4583","LU1066051498.USD"],"gpt_icon":0},{"id":"2522383541","title":"Citi “Very Bullish” on Gilead’s (NASDAQ:GILD) HIV Business","url":"https://stock-news.laohu8.com/highlight/detail?id=2522383541","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522383541?lang=en_us&edition=fundamental","pubTime":"2025-03-26 22:42","pubTimestamp":1743000122,"startTime":"0","endTime":"0","summary":"Citi analysts are “very bullish”on Gilead’s HIV products.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/citi-very-bullish-on-gileads-nasdaqgild-hiv-business?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/citi-very-bullish-on-gileads-nasdaqgild-hiv-business?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PSQ","LU2089984988.USD","QLD","BK4550","SQQQ","LU0109394709.USD","IE00B3T34201.USD","IE00B64PRP62.GBP","LU1066053197.SGD","IE0002270589.USD","LU1839511570.USD","LU2210149790.SGD","USJW.SI",".IXIC","IE00B3QW5Z07.USD","LU2210150020.SGD","LU2095319765.USD","LU2468319806.SGD","LU0058720904.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","NVIW.SI","LU0234570918.USD","LU0320765992.SGD","IE00BKVL7J92.USD","BK4578","BK4568","LU1585245621.USD","IE00BSNM7G36.USD","NDAQ","QID","IE00B19Z3581.USD","BK4566","IE00BKPKM429.USD","LU2087621335.USD","TSYW.SI","LU1571399168.USD","TQQQ","BK4139","BK4583","USAW.SI","MNQmain","GILD","BK4112","IE00BGHQF748.EUR","LU0889565916.HKD","IE00B7SZLL34.SGD","LU1430594728.SGD","NQmain"],"gpt_icon":0},{"id":"2522714381","title":"Are Medical Stocks Lagging  Gilead Sciences (GILD) This Year?","url":"https://stock-news.laohu8.com/highlight/detail?id=2522714381","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522714381?lang=en_us&edition=fundamental","pubTime":"2025-03-26 21:40","pubTimestamp":1742996411,"startTime":"0","endTime":"0","summary":"For those looking to find strong Medical stocks, it is prudent to search for companies in the group that are outperforming their peers. Has Gilead Sciences  been one of those stocks this year?By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we might be able to answer that question.Gilead Sciences is a member of the Medical sector. This group includes 1011 individual stocks and currently holds a Zacks Sector Rank of #5. The Zacks Sector Rank gauges the strength of our 16 individual sector groups by measuring the average Zacks Rank of the individual stocks within the groups.The Zacks Rank is a proven system that emphasizes earnings estimates and estimate revisions, highlighting a variety of stocks that are displaying the right characteristics to beat the market over the next one to three months. Gilead Sciences is currently sporting a Zacks Rank of #2 .Based on the most recent data, GILD has returned 16.8% so far this year. At the same time, Me","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/medical-stocks-lagging-gilead-sciences-134011481.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","ANGO","LU0109394709.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","LU0289739699.SGD","LU1571399168.USD","LU2087621335.USD","BK4568","BK4566","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","BK4082","GILD","LU0234570918.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2522880492","title":"SAVA Stock Down as Alzheimer's Drug Fails in Second Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522880492","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522880492?lang=en_us&edition=fundamental","pubTime":"2025-03-26 19:43","pubTimestamp":1742989380,"startTime":"0","endTime":"0","summary":"Shares of Cassava Sciences SAVA plunged 32.1% on Tuesday after the company announced that its lead pipeline candidate, simufilam, failed to meet the prespecified co-primary endpoints in the second late-stage study for Alzheimer’s disease . Simufilam is SAVA’s proprietary, investigational oral small molecule that targets the filamin A protein.Cassava released top-line results from the phase III REFOCUS-ALZ study, which evaluated simufilam in patients with mild-to-moderate AD. Treatment with the drug failed to achieve a significant reduction in cognitive and functional decline in AD patients when compared to placebo over 76 weeks, as assessed by the ADAS-COG12 and ADCS-ADL scales. The study also failed to meet any pre-specified secondary and exploratory biomarker endpoints.The REFOCUS-ALZ study had enrolled 1,125 AD patients who were randomized equally to receive either a twice-daily, oral dose of simufilam  or placebo for 76 weeks. The candidate, however, demonstrated an acceptable safe","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/sava-stock-down-alzheimers-drug-114300226.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BK4W5M84.HKD","LU0114720955.EUR","BK4532","LU1291159041.SGD","SG9999001176.USD","SSI","IE00BJLML261.HKD","LU0109394709.USD","LU0094547139.USD","LU0096364046.USD","LU0203202063.USD","LU0640476718.USD","LU1280957306.USD","LU1868837136.USD","IE0004445239.USD","SG9999015986.USD","LU0198837287.USD","BK4547","SG9999013999.USD","LU1093756168.USD","SG9999014914.USD","GILD","LU2461242641.AUD","SGXZ81514606.USD","BK4581","LU1988902786.USD","BIIB","LU0006306889.USD","LU2265009873.SGD","SAVA","LU1093756325.SGD","LU0820561909.HKD","LU1917777945.USD","SAVAW","LLY","SG9999017495.SGD","BK4007","IE00BJJMRZ35.SGD","BK4583","LU1839511570.USD","LU2491050071.SGD","LU1057294990.SGD","IE00B1BXHZ80.USD","LU1989771016.USD","SGXZ51526630.SGD","SG9999001176.SGD","BK4566","LU2106854487.HKD","LU0466842654.USD","LU2360106947.USD","LU2112291526.USD"],"gpt_icon":0},{"id":"2522883832","title":"UBX Stock Down 29% on Mixed Results From Phase II Eye Disease Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2522883832","media":"Zacks","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522883832?lang=en_us&edition=fundamental","pubTime":"2025-03-25 23:51","pubTimestamp":1742917860,"startTime":"0","endTime":"0","summary":"Shares of UNITY Biotechnology UBX crashed 28.8% yesterday, following mixed results from a mid-stage non-inferiority study of its lead candidate, intravitreal UBX1325 compared with Regeneron’s REGN Eylea  in diabetic macular edema  patients.The primary efficacy endpoint of the phase IIb ASPIRE study is demonstrating non-inferiority to Eylea, measured by mean change in Best Corrected Visual Acuity from baseline to the average of weeks 20 and 24. The study enrolled 52 DME patients with poor vision despite prior anti-VEGF treatment and was randomized equally to receive either 10 μg UBX1325 or 2 mg of REGN’s Eylea. UBX1325 is UNITY Biotechnology’s novel BCL-xL inhibitor with a unique mechanism of action.The data readout from the mid-stage DME study demonstrated that treatment with the candidate resulted in vision gains, non-inferior to Regeneron’s Eylea, at weeks 24 and 36 in the difficult-to-treat patient population. Patients treated with UBX1325 achieved a +5.2 letter improvement in visua","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/ubx-stock-down-29-mixed-155100201.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4139","IE00BKVL7J92.USD","LU1066053197.SGD","LU2362540622.SGD","LU1066051498.USD","LU0114720955.EUR","BK4568","LU0823416689.USD","BK4566","IE00B3T34201.USD","IE00BSNM7G36.USD","LU2237438978.USD","LU0053666078.USD","LU2089984988.USD","LU0109394709.USD","LU2023250504.SGD","IE00BZ1G4Q59.USD","BK4583","LU0882574055.USD","LU2362541513.USD","LU1839511570.USD","IE0002270589.USD","LU1917777945.USD","BK4532","BK4578","IE00B19Z3B42.SGD","LU1430594728.SGD","LU1974910355.USD","REGN","BK4588","IE00B7SZLL34.SGD","GILD","BK4585","LU0234570918.USD","LU0889565916.HKD","LU2468319806.SGD","LU2087621335.USD","LU1571399168.USD","UBX","LU0058720904.USD","LU0289739699.SGD","LU2362541273.HKD","LU2106854487.HKD","LU0320765992.SGD","LU1585245621.USD","BK4550","IE00B19Z3581.USD","DVAX"],"gpt_icon":1},{"id":"2522708370","title":"Gilead Sciences: Using Lessons From the HIV Epidemic To Help Reduce Stigma Around Lung Cancer","url":"https://stock-news.laohu8.com/highlight/detail?id=2522708370","media":"ACCESS Newswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2522708370?lang=en_us&edition=fundamental","pubTime":"2025-03-25 21:25","pubTimestamp":1742909100,"startTime":"0","endTime":"0","summary":"NORTHAMPTON, MA / ACCESS Newswire / March 25, 2025 / HIV infection and lung cancer have little in common from a disease perspective, but the stigma that surrounds both can negatively impact patients and their treatment. Now lessons learned from the HIV epidemic are helping people living with lung cancer and their loved ones.During the first years of the HIV epidemic, some of the initial stigmatizing beliefs were that the virus only impacted men who have sex with men and that it was possible to contract it by sharing utensils or being in close confines with a person living with HIV. This helped contribute to acts of discrimination and an atmosphere of blame, and in some cases prevented people from getting diagnosed or seeking care.People diagnosed with lung cancer face similar stigma challenges because of the known link to tobacco use - despite the National Cancer Institute's estimate that 10-20% of people with lung cancer in the United States are non-smokers. As with HIV, the blame and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-using-lessons-hiv-132500779.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","BK4566","LU0289739699.SGD","IE00BSNM7G36.USD","BK4583","GILD","IE00B19Z3581.USD","BK4578","LU0320765992.SGD","BK4568","LU1585245621.USD","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4550","LU1430594728.SGD","LU2468319806.SGD","BK4139","LU1839511570.USD","LU0109394709.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4532","LU1066051498.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4588","LU1571399168.USD","IE0002270589.USD","LU0889565916.HKD","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2521584612","title":"Alnylam Gets FDA Nod for Expanded Use of Amvuttra in Cardiomyopathy","url":"https://stock-news.laohu8.com/highlight/detail?id=2521584612","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521584612?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:46","pubTimestamp":1742575560,"startTime":"0","endTime":"0","summary":"ALNY’s Amvuttra, an RNAi therapeutic, was previously approved in the United States for treating adult patients with polyneuropathy associated with transthyretin-mediated amyloidosis . It is also marketed in the EU for treating hATTR-PN in adult patients with stage 1 or stage 2 polyneuropathy.The FDA’s latest nod makes Amvuttra the first and only therapeutic approved in the United Statesfor both ATTR-CM and hATTR-PN in adults, marking a significant milestone achievement. ATTR-CM is a severe, rapidly progressing, and life-threatening disease affecting an estimated 150,000 people in the United States and over 300,000 globally. Despite its impact, most cases go undiagnosed and untreated, while many patients receiving standard therapies continue to experience disease progression.The approval of Amvuttra’s supplemental new drug application  for the ATTR-CM indication is based on positiveresults from Alnylam’s pivotal phase III HELIOS-B study of the drug, which met all primary and secondary e","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/alnylam-gets-fda-nod-expanded-164600244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BJJMRZ35.SGD","IE00BJT1NW94.SGD","BK4139","LU0234570918.USD","LU1066051498.USD","ALNY","LU2089984988.USD","IE00BFTCPJ56.SGD","IE0009355771.USD","BK4532","LU1839511570.USD","LU2087621335.USD","LU0058720904.USD","IE00B19Z3B42.SGD","LU0070302665.USD","IE0002270589.USD","BK4548","LU1571399168.USD","LU1066053197.SGD","IE0002141913.USD","NVS","LU0211331839.USD","IE00B19Z3581.USD","BK4550","BK4583","IE00BKVL7J92.USD","LU0208291251.USD","LU0109394709.USD","IE00B4R5TH58.HKD","BK4007","LU0889565916.HKD","LU1585245621.USD","BK4578","IE00B2B36J28.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU0289739699.SGD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD","BK4566","IE00B3T34201.USD","LU0320765489.SGD","DVAX","BK4585","GILD","LU0320765992.SGD","BK4588","BK4568","LU2468319806.SGD"],"gpt_icon":0},{"id":"2521462258","title":"OPTN Stock Soars 53% on Inking $330M Deal to be Acquired by Paratek","url":"https://stock-news.laohu8.com/highlight/detail?id=2521462258","media":"Zacks","labels":["merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521462258?lang=en_us&edition=fundamental","pubTime":"2025-03-22 00:44","pubTimestamp":1742575440,"startTime":"0","endTime":"0","summary":"Shares of OptiNose OPTN soared 52.5% on Thursday after the company announced that it is set to be acquired by Paratek Pharmaceuticals, a private biotech. This deal will add OPTN’s approved product, Xhance , to the latter’s commercial portfolio.Xhance is an innovative drug-device therapy for chronic rhinosinusitis , with or without nasal polyps. Utilizing its proprietary Exhalation Delivery System, it delivers a corticosteroid directly to the site of inflammation, improving patient outcomes while potentially reducing the need for invasive or costly treatments.The acquisition enables OptiNose to expand Xhance’s market reach, addressing long-standing challenges in adoption. Paratek’s strong commercial infrastructure will help drive awareness, particularly among primary care providers who treat most CRS patients.Paratek’s recently expanded primary care field force, combined with OptiNose’s specialist sales expertise, positions the company to accelerate Xhance’s adoption across both ear, no","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/optn-stock-soars-53-inking-164400660.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE0002270589.USD","LU0109394709.USD","IE00B19Z4B17.USD","IE00B19Z3B42.SGD","LU1066053197.SGD","BK4583","IE00B7SZLL34.SGD","LU2468319806.SGD","BK4585","BK4139","BK4550","IE00BSNM7G36.USD","LU0058720904.USD","BK4588","DVAX","LU0289739699.SGD","IE00B66KJ199.SGD","LU1571399168.USD","LU2087621335.USD","BK4568","BK4566","ARVN","LU1430594728.SGD","LU1585245621.USD","LU2089984988.USD","BK4006","IE00BKVL7J92.USD","LU0320765992.SGD","BK4578","IE00B19Z3581.USD","OPTN","IE00B7SZL793.SGD","GILD","LU2065731478.USD","BK4007","LU0234570918.USD","LU1066051498.USD","IE0031619046.USD","IE00BZ1G4Q59.USD","BK4532","LU0889565916.HKD","LU1839511570.USD","IE00B3T34201.USD","CRS"],"gpt_icon":0},{"id":"2521280795","title":"Trump Trade: President to sign EO on DOE, weighing Chevron license extension","url":"https://stock-news.laohu8.com/highlight/detail?id=2521280795","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521280795?lang=en_us&edition=fundamental","pubTime":"2025-03-21 22:16","pubTimestamp":1742566575,"startTime":"0","endTime":"0","summary":"Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly:. Discover stocks' market position with detailed  competitor analyses.FLOCK TO REDDIT: In recent months, Reddit  has become a lifeline for government workers, Kashmir Hill of The New York Times reports. With the Trump administration downsizing the federal bureaucracy, government subreddits have become crowded forums for fear, anxieties, and intra-agency observations. On one subreddit called FedNews, government employees have provided updates on the layoffs, a new $1 limit on government credit cards, and the “what did you accomplish last week” emails. Reddit has drawn an influx of millions of visitors since January, according to internal statistics shared by the subreddit’s creator.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/trump-trade-president-sign-eo-141615113.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trump-trade-president-sign-eo-141615113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4571","LU1989772840.SGD","LU1582987597.SGD","LU0149725797.USD","LU0784384876.USD","LU0787776722.HKD","LU0889565833.HKD","MACW.SI","LU0672654240.SGD","BK4602","LU0642271901.SGD","BK4507","LU0353189763.USD","LU1066051225.USD","LU0689472784.USD","IE00BN29S564.USD","LU0266512127.USD","LU0689626769.HKD","LU0278409577.USD","LU1162221912.USD","LU2111349929.HKD","LU2452424414.USD","IE00B5949003.HKD","IE00BKVL7J92.USD","LU1868836591.USD","LU0965508806.USD","TSM","LU0820562030.AUD","IE00BJTD4V19.USD","AAPL","LU1974910355.USD","LU0251132253.USD","LU1861215975.USD","GILD","IE0009356076.USD","CVX","RDDT","LU0215105999.USD","LU0541502299.USD","LU0943347566.SGD","BK4201","LU0640476718.USD","LU0320765489.SGD","LU1852331112.SGD","SG9999014542.SGD","IE00BJTD4N35.SGD","LU0256863902.USD","LU1571399168.USD","LU0124676726.USD","03145"],"gpt_icon":1},{"id":"2521289085","title":"Is VanEck Morningstar Wide Moat ETF (MOAT) a Strong ETF Right Now?","url":"https://stock-news.laohu8.com/highlight/detail?id=2521289085","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521289085?lang=en_us&edition=fundamental","pubTime":"2025-03-21 18:20","pubTimestamp":1742552406,"startTime":"0","endTime":"0","summary":"Designed to provide broad exposure to the Style Box - Large Cap Blend category of the market, the VanEck Morningstar Wide Moat ETF  is a smart beta exchange traded fund launched on 04/24/2012.The ETF industry has traditionally been dominated by products based on market capitalization weighted indexes that are designed to represent the market or a particular segment of the market.Market cap weighted indexes offer a low-cost, convenient, and transparent way of replicating market returns, and are a good option for investors who believe in market efficiency.There are some investors, though, who think it's possible to beat the market with great stock selection; this group likely invests in another class of funds known as smart beta, which track non-cap weighted strategies.The fund is sponsored by Van Eck. It has amassed assets over $13.84 billion, making it one of the largest ETFs in the Style Box - Large Cap Blend. MOAT, before fees and expenses, seeks to match the performance of the Morni","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/vaneck-morningstar-wide-moat-etf-102006100.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU1868836757.USD","LU1868836914.USD",".SPX","ESmain","LU0114720955.EUR","DIS","BK4583","LU0310800379.SGD","SSO","BK4581","LU2133065610.SGD","LU1670711040.USD","LU1585245621.USD","LU1894683348.USD","BMY","LU1718418525.SGD","LU0251142724.SGD","LU1093756168.USD","LU0321505868.SGD","LU1989771016.USD","IE0002141913.USD","SPY","MOAT","OEF","FDN","MORN","LU0234570918.USD","LU0786609619.USD","LU1868836591.USD","VOO","LU0058720904.USD","GILD","LU1670710588.SGD","LU2468319806.SGD","BK4550","LU0742534661.SGD","IVV","LU2360032135.SGD","LU0708994859.HKD","BK4524","SG9999015952.SGD","SPXU","OEX","UPRO","LU1280957306.USD","LU0029864427.USD","SDS","LU0237698245.USD","BK4507","SH"],"gpt_icon":1},{"id":"2521403218","title":"The Zacks Analyst Blog Highlights Sarepta Therapeutics, Incyte, Gilead Sciences and VTv Therapeutics","url":"https://stock-news.laohu8.com/highlight/detail?id=2521403218","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521403218?lang=en_us&edition=fundamental","pubTime":"2025-03-21 16:46","pubTimestamp":1742546760,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 21, 2025 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include: Sarepta Therapeutics SRPT, Incyte INCY, Gilead Sciences, Inc. GILD and VTv Therapeutics Inc. VTVT.It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Sarepta Therapeutics crashed following a report of a patient's death after treatment with Elevidys. Incyte also declined after study data disappointed investors.GILD boasts a market-leading portfolio of HIV treatments both for treating the disease and prevention. The company has two drugs for HIV prevention in its portfolio – Descovy and Truvada. Gilead to looking to get another drug approved for HIV prevention – lenacapavir.Per the report, while programs do provide free pre-exposure prophylaxis, reductions to the s","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-analyst-blog-highlights-sarepta-084600176.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["INCY","BK4566","VTVT","LU1571399168.USD","LU2087621335.USD","BK4585","BK4503","SRPT","QD","LU1585245621.USD","BK4578","IE00BFTCPJ56.SGD","IE00B19Z3581.USD","LU0289739699.SGD","IE0002270589.USD","LU0058720904.USD","LU0234570918.USD","IE00BSNM7G36.USD","IE00B19Z3B42.SGD","IE00BZ1G4Q59.USD","GILD","BK4532","LU2089984988.USD","IE00B2B36J28.USD","LU0109394709.USD","LU0889565916.HKD","BK4139","IE0009355771.USD","IE00B7SZLL34.SGD","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD","BK4583","LU1430594728.SGD","LU1066051498.USD","BK4563","ADME","IE0002141913.USD","BK4568","LU1066053197.SGD","LU1839511570.USD","BK4588","LU0320765992.SGD","LU2468319806.SGD","IE00BKVL7J92.USD","BK4550","BK4166","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2521534426","title":"Incyte Had a Bad Week. Investors Are Used to It. -- Barrons.com","url":"https://stock-news.laohu8.com/highlight/detail?id=2521534426","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521534426?lang=en_us&edition=fundamental","pubTime":"2025-03-21 14:30","pubTimestamp":1742538600,"startTime":"0","endTime":"0","summary":"Incyte's quest for its next big thing ended in disappointment -- and a stock tumble -- this past week. Unfortunately, the problems go well beyond the recent selloff or the latest trial, as long-term investors in the biotech know all too well.Incyte tumbled more than 8% earlier this week after disappointing Phase 3 study results for povorcitinib, a drug that targets severe hidradenitis suppurativa . Strong Phase 2 data had lifted hopes for the treatment for the condition that causes chronic boils and abscesses under the skin, but the final results were less promising than the prior study in terms of efficacy and perceived competitive positioning.Over the past decade, when the S&P 500 index has risen 175%, Incyte has fallen by a third. The SPDR S&P Biotech and iShares Biotechnology exchange-traded funds have hardly kept pace with the broader market either, but at least both are in positive territory, up around 15% over the period","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4578","INCY","BK4532","BK4583","IE00B19Z3581.USD","LU2087621335.USD","IE00B3T34201.USD","LU0058720904.USD","BK4139","IE00BKVL7J92.USD","IE00B19Z3B42.SGD","LU1571399168.USD","BK4588","BK4550","LU0289739699.SGD","LU2468319806.SGD","BK4211","LU0109394709.USD","BK4566","BK4585","IE00B7SZLL34.SGD","IE0002270589.USD","GILD","LU0889565916.HKD","LU0234570918.USD","LU2089984988.USD","LU1430594728.SGD","BK4568","LU1839511570.USD","LU1066053197.SGD","ISBC","LU0320765992.SGD","LU1585245621.USD","LU1066051498.USD","IE00BZ1G4Q59.USD","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"2521157784","title":"Gilead Sciences (GILD) Suffers a Larger Drop Than the General Market: Key Insights","url":"https://stock-news.laohu8.com/highlight/detail?id=2521157784","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521157784?lang=en_us&edition=fundamental","pubTime":"2025-03-21 06:00","pubTimestamp":1742508018,"startTime":"0","endTime":"0","summary":"The most recent trading session ended with Gilead Sciences  standing at $105.87, reflecting a -1.53% shift from the previouse trading day's closing. This change lagged the S&P 500's daily loss of 0.22%. Elsewhere, the Dow lost 0.03%, while the tech-heavy Nasdaq lost 0.33%.Prior to today's trading, shares of the HIV and hepatitis C drugmaker had lost 0.13% over the past month. This has was narrower than the Medical sector's loss of 0.63% and the S&P 500's loss of 7.48% in that time.Investors will be eagerly watching for the performance of Gilead Sciences in its upcoming earnings disclosure. The company is predicted to post an EPS of $1.73, indicating a 231.06% growth compared to the equivalent quarter last year. Meanwhile, the Zacks Consensus Estimate for revenue is projecting net sales of $6.78 billion, up 1.36% from the year-ago period.The Zacks Industry Rank evaluates the power of our distinct industry groups by determining the average Zacks Rank of the individual stocks forming the ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/gilead-sciences-gild-suffers-larger-220018533.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B7SZLL34.SGD","BK4566","LU0289739699.SGD","IE00BSNM7G36.USD","BK4583","GILD","IE00B19Z3581.USD","BK4578","LU0320765992.SGD","BK4568","LU1585245621.USD","LU0234570918.USD","LU2089984988.USD","IE00BZ1G4Q59.USD","LU0058720904.USD","BK4550","LU1430594728.SGD","LU2468319806.SGD","BK4139","LU1839511570.USD","LU0109394709.USD","LU1066053197.SGD","IE00B3T34201.USD","BK4532","LU1066051498.USD","LU2087621335.USD","IE00B19Z3B42.SGD","BK4588","LU1571399168.USD","IE0002270589.USD","LU0889565916.HKD","BK4585","IE00BKVL7J92.USD"],"gpt_icon":0},{"id":"2521493395","title":"Biotech Stock Roundup: Patient Death Hits SRPT, INCY Study Data & More","url":"https://stock-news.laohu8.com/highlight/detail?id=2521493395","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521493395?lang=en_us&edition=fundamental","pubTime":"2025-03-21 00:45","pubTimestamp":1742489100,"startTime":"0","endTime":"0","summary":"It was a busy week in the biotech sector with important regulatory and pipeline updates. Among these, Sarepta Therapeutics SRPT crashed following report of a patient death after treatment with Elevidys. Incyte INCY also declined after study data disappointed investors.Shares of Sarepta Therapeutics plunged earlier in the week after it reported the death of a patient after treatment with Elevidys, its one-shot gene therapy for Duchenne muscular dystrophy .Per the company, this patient died of acute liver failure. While acute liver injury is a known risk of Elevidys, this is the first time a death has been reported of anyone taking the therapy. However, Sarepta stated that the patient also had a recent cytomegalovirus  infection, which may have contributed to the outcome, as CMV can damage the liver.HS, a chronic inflammatory skin condition, is characterized by painful nodules and abscesses.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/biotech-stock-roundup-patient-death-164500168.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00BFTCPJ56.SGD","LU1839511570.USD","IE00B3T34201.USD","IE00BJJMRZ35.SGD","VTVT","BK4585","IE00B7SZLL34.SGD","BK4139","BK4578","IE0002141913.USD","LU0058720904.USD","LU1585245621.USD","BK4166","IE00BZ1G4Q59.USD","LU1571399168.USD","LU0109394709.USD","BK4568","LU1066051498.USD","LU2468319806.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","IE0009355771.USD","LU0889565916.HKD","BK4550","BK4583","BK4532","QD","IE00B2B36J28.USD","BK4566","IE00BJT1NW94.SGD","LU2087621335.USD","LU0289739699.SGD","LU2089984988.USD","LU0320765992.SGD","SRPT","ADME","IE00BSNM7G36.USD","LU1066053197.SGD","BK4563","BK4503","IE00B19Z3B42.SGD","IE0002270589.USD","LU0234570918.USD","GILD","IE00B19Z3581.USD","INCY","BK4588"],"gpt_icon":0},{"id":"2521461815","title":"IMVT Unlikely to Pursue Batoclimab for MG & CIDP Despite Success","url":"https://stock-news.laohu8.com/highlight/detail?id=2521461815","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2521461815?lang=en_us&edition=fundamental","pubTime":"2025-03-20 22:19","pubTimestamp":1742480340,"startTime":"0","endTime":"0","summary":"Immunovant IMVT announced top-line data from a late-stage study of its investigational candidate, batoclimab, for myasthenia gravis  and initial results from Period 1 of a mid-stage study of the same candidate for chronic inflammatory demyelinating polyneuropathy .IMVT’s Batoclimab Shows Superior Efficacy in MG Patients. The phase III study is evaluating the efficacy and safety of batoclimab in adult patients with moderate to severe MG. Per the data readout, the study met its primary endpoint of mean change from baseline in the MG Activities of Daily Living  score, used to determine the impact of weekly or bi-monthly doses of batoclimab, in acetylcholine receptor antibody positive  patients after 12 weeks.Immunovant reported that MG patients who received the weekly680mg subcutaneous dose of batoclimab achieved a 5.6-point improvement in MG-ADL and a 4.7-point improvement was observed in patients receiving the 340mg dose compared to a 3.6-point improvement in the placebo group at week 1","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/imvt-unlikely-pursue-batoclimab-mg-141900033.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MG","IE0002270589.USD","BK4585","BK4123","BK4568","IE0031619046.USD","LU0889565916.HKD","LU1571399168.USD","LU1839511570.USD","LU2087621335.USD","IE00BSNM7G36.USD","BK4588","IE00B19Z3581.USD","IMVT","IE00BKVL7J92.USD","BK4139","IE00B19Z4B17.USD","BK4583","LU0058720904.USD","LU1066053197.SGD","BK4578","LU0320765992.SGD","BK4007","LU0234570918.USD","IE00B66KJ199.SGD","LU2468319806.SGD","BK4532","GILD","BK4550","ARVN","LU1430594728.SGD","IE00BZ1G4Q59.USD","IE00B7SZL793.SGD","LU1585245621.USD","LU0109394709.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","LU1066051498.USD","LU2089984988.USD","LU0289739699.SGD","DVAX","BK4566","IE00B3T34201.USD"],"gpt_icon":0},{"id":"2520457945","title":"Trump Trade: Reciprocal tariffs still to start on April 2","url":"https://stock-news.laohu8.com/highlight/detail?id=2520457945","media":"TipRanks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520457945?lang=en_us&edition=fundamental","pubTime":"2025-03-20 22:00","pubTimestamp":1742479258,"startTime":"0","endTime":"0","summary":"Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly:. Discover stocks' market position with detailed  competitor analyses.HIV PREVENTION: The Health and Human Services Department is weighing plans to “drastically” cut the federal government’s funding for domestic HIV prevention, people familiar with the matter told The Wall Street Journal‘s Liz Essley Whyte, Dominique Mosbergen and Jonathan Rockoff. Plans could be announced as soon as within a day, though they haven’t been finalized and could be pulled back or adjusted, the report noted. ViiV Healthcare, the global specialist HIV company majority owned by GSK , with Pfizer  and Shionogi  as shareholders, as well as Gilead Sciences  are makers of HIV prevention treatments.CONDITIONAL APPROVAL: The Trump administration is set to give Venture Global  conditional approval to export natural ga","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/trump-trade-reciprocal-tariffs-still-140058956.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trump-trade-reciprocal-tariffs-still-140058956.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TRUMP.USD.CC","IE00BDCRKT87.USD","IE00B4JS1V06.HKD","LU0353189763.USD","BK4534","BK4097","GOOG","LU0238689110.USD","LU2286300806.USD","CLF","SGXZ31699556.SGD","ROKU","GSK.UK","BK4532","LU0742534661.SGD","LU0265550359.USD","LU2764262908.HKD","LU0267386448.USD","X","BK4503","GSK","LU1221951046.USD","SG9999003800.SGD","LU2065169927.USD","SGXZ99366536.SGD","LU0640476718.USD","BK4550","SGIOY","LU2468319806.SGD","LU1670710661.SGD","LU0127658192.USD","DJTWW","STLD","LU1059921491.USD","GILD","DJT","LU1551013342.USD","LU1623119135.USD","MSFT","NUE","LU1712237335.SGD","VG","LU0788109121.HKD","LU2417539215.USD","LU0203202063.USD","GOOGL","LU1023059063.AUD","BK4006","LU0170899867.USD","PFE","IE0004091025.USD","MT"],"gpt_icon":1},{"id":"2520468110","title":"Novartis Reports Updated Positive Data From Phase III SMA Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2520468110","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520468110?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:34","pubTimestamp":1742477640,"startTime":"0","endTime":"0","summary":"NovartisNVS reported promising new safety and efficacy results from its phase III studies of investigational intrathecal onasemnogene abeparvovec  in a broad group of patients aged 2 to under 18 years with spinal muscular atrophy . OAV101 IT is an investigational, one-time gene therapy for patients with SMA.Additionally, in the phase IIIb STRENGTH study, treatment with OAV101 IT demonstrated stabilization of motor function over 52 weeks of follow-up in patients who had previously discontinued treatment with Spinraza  or Roche’s RHHBY Evrysdi .SMA, a rare, genetic neuromuscular disease caused by a lack of a functional SMN1 gene, results in the irreversible loss of motor neurons, affecting muscle functions, including breathing, swallowing and basic movement.Year to date, shares of Novartis have gained 14.6% compared with the industry’s 7.2% growth.Novartis presented these data at a recent medical conference held in Dallas, Texas. Per NVS, OAV101 IT is the first investigational gene repla","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/novartis-reports-updated-positive-data-133400414.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0211331839.USD","IE00BKVL7J92.USD","IE00B19Z3581.USD","LU1066053197.SGD","03165","LU1066051498.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00BSNM7G36.USD","IE00BJT1NW94.SGD","BK4139","LU0070302665.USD","GILD","IE00BJJMRZ35.SGD","IE00B3T34201.USD","BK4550","IE00B19Z3B42.SGD","LU1585245621.USD","LU1430594728.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4585","IE00B7SZLL34.SGD","LU0320765992.SGD","LU0109394709.USD","IE0002141913.USD","LU0289739699.SGD","LU1839511570.USD","BK4532","LU0320765489.SGD","BK4583","BK4588","LU1571399168.USD","LU0234570918.USD","BK4566","LU2087621335.USD","LU2089984988.USD","BK4007","IE00BZ1G4Q59.USD","NVS","BK4578","LU0058720904.USD","RHHBY","III","IE0002270589.USD","LU0208291251.USD","LU0889565916.HKD","BK4134","DVAX","BK4568"],"gpt_icon":0},{"id":"2520746310","title":"Brokers Suggest Investing in Gilead (GILD): Read This Before Placing a Bet","url":"https://stock-news.laohu8.com/highlight/detail?id=2520746310","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520746310?lang=en_us&edition=fundamental","pubTime":"2025-03-20 21:30","pubTimestamp":1742477410,"startTime":"0","endTime":"0","summary":"The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed  analysts changing their ratings often affect a stock's price. Do they really matter, though?Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Gilead Sciences .Gilead currently has an average brokerage recommendation  of 1.73, on a scale of 1 to 5 , calculated based on the actual recommendations  made by 30 brokerage firms. An ABR of 1.73 approximates between Strong Buy and Buy.Of the 30 recommendations that derive the current ABR, 19 are Strong Buy, representing 63.3% of all recommendations.Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support becau","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/brokers-suggest-investing-gilead-gild-133010244.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["GILD","IE00B3T34201.USD","IE00B7SZLL34.SGD","LU1571399168.USD","LU1839511570.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU2089984988.USD","BK4110","LU0058720904.USD","LU2468319806.SGD","BK4583","IE00BSNM7G36.USD","LU0289739699.SGD","BK4550","ABR","BK4139","IE00B19Z3B42.SGD","BK4585","BK4566","LU1066051498.USD","BK4578","IE00BKVL7J92.USD","LU0234570918.USD","BK4532","LU2087621335.USD","LU0889565916.HKD","LU1430594728.SGD","LU0109394709.USD","LU1585245621.USD","LU1066053197.SGD","BK4568","IE00B19Z3581.USD","IE0002270589.USD","BK4588"],"gpt_icon":0},{"id":"2520463481","title":"Company News for Mar 20, 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2520463481","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520463481?lang=en_us&edition=fundamental","pubTime":"2025-03-20 20:47","pubTimestamp":1742474820,"startTime":"0","endTime":"0","summary":"Shares of Tesla, Inc.  rose 4.7% after gaining a California permit for ride-hailing services, according to a Bloomberg report.General Mills, Inc.  shares fell 2.1% after reporting fourth-quarter 2024 revenues of $4.84 billion, missing the Zacks Consensus Estimate by 2.28%.Gilead Sciences, Inc.  shares fell 2.5% following a Wall Street Journal report that the Trump administration may cut funding for domestic HIV prevention.Shares of HealthEquity, Inc.  plunged 17.1% after reporting fourth-quarter 2024 earnings of $0.69 per share, missing the Zacks Consensus Estimate of $ 0.71 per share.Want the latest recommendations from Zacks Investment Research?Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report. This article originally published on Zacks Investment Research .","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/company-news-mar-20-2025-124700402.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4099","TSYW.SI","LU1366192091.USD","BK4604","LU2065731478.USD","LU2471134796.USD","LU0056508442.USD","LU0058720904.USD","LU0943347566.SGD","LU0345769631.USD","LU2360106780.USD","IE00B19Z3B42.SGD","LU1551013342.USD","LU0234570918.USD","LU1066051811.HKD","LU2750360641.GBP","LU0289739699.SGD","LU0345770308.USD","BK4555","LU1861220033.SGD","IE00BZ1G4Q59.USD","GILD","LU0348723411.USD","LU2023250330.USD","LU1571399168.USD","BK4212","IE00BK4W5L77.USD","LU2750360997.AUD","IE00B3T34201.USD","BK4598","BK4566","LU2360107168.USD","IE0002270589.USD","LU2471134952.CNY","SG9999015986.USD","LU1778281490.HKD","LU1674673428.USD","BK4548","GIS","LU0719512351.SGD","LU2290526834.HKD","HQY","LU2471134879.HKD","LU2602419157.SGD","SG9999015978.USD","TSLA","LU0823414478.USD","LU1145028129.USD","LU2108987350.USD","BK4583"],"gpt_icon":1},{"id":"2520121482","title":"Trump Administration Weighs Deep Cuts To Domestic HIV Prevention Programs, Gilead Stock Slides","url":"https://stock-news.laohu8.com/highlight/detail?id=2520121482","media":"Benzinga","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2520121482?lang=en_us&edition=fundamental","pubTime":"2025-03-20 10:36","pubTimestamp":1742438174,"startTime":"0","endTime":"0","summary":"Benzinga and Yahoo Finance LLC may earn commission or revenue on some items through the links below.Gilead Sciences Inc  stock is trading lower during the premarket trading session on Wednesday.According to a Tuesday report in the Wall Street Journal, the Health and Human Services Department  is considering substantial reductions in federal funding for domestic HIV prevention.According to people familiar with the matter, the WSJ reports that the plans could be announced within a day. However, they are not final and could still be changed or canceled.Maker of the $60,000 foldable home has 3 factory buildings, 600+ houses built, and big plans to solve housing — you can become an investor for $0.80 per share today.The Centers for Disease Control and Prevention  has a department focused on preventing HIV and other infectious diseases. It provides funding for state and local programs, including HIV tracking, syringe services, and community outreach, the WSJ writes.Gilead alsorevealed that i","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/trump-administration-weighs-deep-cuts-023614509.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999003800.SGD","IE00B7SZLL34.SGD","SG9999001176.SGD","LU1023059063.AUD","LU0058720904.USD","BK4533","LU2089984988.USD","BK4139","SG9999002224.SGD","BK4550","IE00B19Z3B42.SGD","BK4007","LU0321505868.SGD","IE00BZ1G4Q59.USD","LU0306807586.USD","GILD","LU0320765992.SGD","BK4009","HHS","LU0321505439.SGD","LU0234572021.USD","SG9999001176.USD","BK4585","BK4592","BK4568","BK4583","LU0234570918.USD","LU1066053197.SGD","GSK.UK","CDC","IE00BLSP4452.SGD","LU0109394709.USD","IE00B3T34201.USD","IE00BSNM7G36.USD","SGXZ57979304.SGD","LU0868494617.USD","LU1883839398.USD","LU1829250122.USD","LU1894683264.USD","GSK","BK4534","BK4581","LU0456855351.SGD","BK4599","SG9999011175.SGD","LU0170899867.USD","LU0289739699.SGD","LU1571399168.USD","LU0889565916.HKD"],"gpt_icon":1}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/GILD\",params:#limit:5,,,undefined,":[{"date":"2025-04-24","symbol":"GILD","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":1.75,"defaultRemindTime":1745524800000,"name":null,"time":"Post Market","dateTimestamp":1745467200000,"actualEps":null},{"date":"2025-03-14","symbol":"GILD","amount":0.79,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-14","defaultRemindTime":1741959000000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-28","payableDate":"2025-03-14","currency":"USD","dateTimestamp":1741924800000,"payDate":"2025-03-28"},{"market":"US","date":"2025-02-11","symbol":"GILD","fiscalQuarterEnding":"2024/12","expectedEps":1.67,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1739250000000,"reportTimeType":"post","actualEps":1.9},{"date":"2024-12-13","symbol":"GILD","amount":0.77,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-13","defaultRemindTime":1734100200000,"name":"吉利德科学","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-30","payableDate":"2024-12-13","currency":"USD","dateTimestamp":1734066000000,"payDate":"2024-12-30"},{"market":"US","date":"2024-11-06","symbol":"GILD","fiscalQuarterEnding":"2024/09","expectedEps":1.58,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1730869200000,"reportTimeType":"post","actualEps":2.02}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"GILD\",market:\"US\",,,undefined,":[{"executeDate":"2015-06-12","recordDate":"2015-06-16","paymentDate":"2015-06-29","value":0.43,"currency":"USD"},{"executeDate":"2015-09-14","recordDate":"2015-09-16","paymentDate":"2015-09-29","value":0.43,"currency":"USD"},{"executeDate":"2015-12-14","recordDate":"2015-12-16","paymentDate":"2015-12-30","value":0.43,"currency":"USD"},{"executeDate":"2016-03-14","recordDate":"2016-03-16","paymentDate":"2016-03-30","value":0.43,"currency":"USD"},{"executeDate":"2016-06-14","recordDate":"2016-06-16","paymentDate":"2016-06-29","value":0.47,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"GILD\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3,"buy":0.3333,"hold":0.3667,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":30,"updateTime":1742443200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/GILD\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"GILD","date":"2025-04-22","current":270.961196,"percent":0.817143,"low":-353.030459,"twenty":16.17325,"median":19.270108,"eighty":174.419449,"high":985.638037,"avg":115.654755,"sd":257.282824,"marketCap":130061374150},"quantilePoints":[{"date":"2020-04-24","current":18.616407,"twenty":6.427197,"median":14.646819,"eighty":30.203766,"marketCap":100267968138},{"date":"2020-05-01","current":20.205018,"twenty":6.427197,"median":14.646819,"eighty":30.040279,"marketCap":100257300000},{"date":"2020-05-08","current":19.589157,"twenty":6.427197,"median":14.646819,"eighty":29.863518,"marketCap":97201394766},{"date":"2020-05-15","current":19.278218,"twenty":6.427197,"median":14.646819,"eighty":29.6922,"marketCap":95658515484},{"date":"2020-05-22","current":18.540053,"twenty":6.427197,"median":14.646819,"eighty":29.202205,"marketCap":91995745156},{"date":"2020-05-29","current":19.675107,"twenty":6.427197,"median":14.646819,"eighty":29.042662,"marketCap":97627881722},{"date":"2020-06-05","current":19.402088,"twenty":6.427197,"median":14.646819,"eighty":28.831708,"marketCap":96273158450},{"date":"2020-06-12","current":18.504662,"twenty":6.427197,"median":14.646819,"eighty":27.315326,"marketCap":91820132880},{"date":"2020-06-19","current":19.584101,"twenty":6.427197,"median":14.646819,"eighty":26.917351,"marketCap":97176307298},{"date":"2020-06-26","current":18.850992,"twenty":6.427197,"median":14.646819,"eighty":26.756696,"marketCap":93538624438},{"date":"2020-07-02","current":19.300969,"twenty":6.427197,"median":14.646819,"eighty":26.63808,"marketCap":95771409090},{"date":"2020-07-10","current":19.293385,"twenty":6.427197,"median":14.646819,"eighty":26.355806,"marketCap":95733777888},{"date":"2020-07-17","current":19.594212,"twenty":6.427197,"median":14.646819,"eighty":25.598322,"marketCap":97226482234},{"date":"2020-07-24","current":18.615892,"twenty":6.427197,"median":14.646819,"eighty":25.376857,"marketCap":92372057176},{"date":"2020-07-31","current":-339.364134,"twenty":6.410323,"median":14.629784,"eighty":25.277011,"marketCap":87216582502},{"date":"2020-08-07","current":-338.310448,"twenty":6.392142,"median":14.560725,"eighty":25.150137,"marketCap":86945785059},{"date":"2020-08-14","current":-334.163889,"twenty":6.380126,"median":14.488429,"eighty":25.150137,"marketCap":85880119345},{"date":"2020-08-21","current":-324.407279,"twenty":6.34887,"median":14.451741,"eighty":25.150137,"marketCap":83372670605},{"date":"2020-08-28","current":-318.35818,"twenty":6.326168,"median":14.415069,"eighty":25.150137,"marketCap":81818052386},{"date":"2020-09-04","current":-322.016909,"twenty":6.300695,"median":14.353547,"eighty":25.150137,"marketCap":82758345663},{"date":"2020-09-11","current":-319.919238,"twenty":6.282152,"median":14.321176,"eighty":25.150137,"marketCap":82219244184},{"date":"2020-09-18","current":-317.333736,"twenty":6.244206,"median":14.279358,"eighty":25.150137,"marketCap":81554770268},{"date":"2020-09-25","current":-303.674483,"twenty":6.163333,"median":14.261828,"eighty":25.150137,"marketCap":78044342032},{"date":"2020-10-02","current":-303.284218,"twenty":6.038611,"median":14.169569,"eighty":25.150137,"marketCap":77944044082},{"date":"2020-10-09","current":-311.430987,"twenty":5.952564,"median":14.135621,"eighty":25.150137,"marketCap":80037763780},{"date":"2020-10-16","current":-302.454906,"twenty":5.912527,"median":14.104836,"eighty":25.150137,"marketCap":77730910940},{"date":"2020-10-23","current":-296.552157,"twenty":5.894484,"median":14.057828,"eighty":25.150137,"marketCap":76213904452},{"date":"2020-10-30","current":57.495325,"twenty":5.887283,"median":14.035041,"eighty":25.277011,"marketCap":72904072115},{"date":"2020-11-06","current":58.395826,"twenty":5.887283,"median":14.035041,"eighty":25.376857,"marketCap":74045907761},{"date":"2020-11-13","current":59.893535,"twenty":5.887283,"median":14.035041,"eighty":25.598322,"marketCap":75945002907},{"date":"2020-11-20","current":59.423957,"twenty":5.887283,"median":14.035041,"eighty":26.355806,"marketCap":75349577036},{"date":"2020-11-27","current":59.34487,"twenty":5.887283,"median":14.035041,"eighty":26.598291,"marketCap":75249294784},{"date":"2020-12-04","current":60.857408,"twenty":5.887283,"median":14.035041,"eighty":26.756696,"marketCap":77167192852},{"date":"2020-12-11","current":60.066538,"twenty":5.887283,"median":14.035041,"eighty":26.917351,"marketCap":76164370333},{"date":"2020-12-18","current":58.405712,"twenty":5.887283,"median":14.035041,"eighty":27.315326,"marketCap":74058443042},{"date":"2020-12-24","current":56.418653,"twenty":5.887283,"median":14.035041,"eighty":28.776154,"marketCap":71538851463},{"date":"2020-12-31","current":57.595071,"twenty":5.887283,"median":14.035041,"eighty":28.982603,"marketCap":73030549960},{"date":"2021-01-08","current":62.320516,"twenty":5.887283,"median":14.035041,"eighty":29.131999,"marketCap":79022414512},{"date":"2021-01-15","current":62.607206,"twenty":5.887283,"median":14.035041,"eighty":29.690755,"marketCap":79385937676},{"date":"2021-01-22","current":66.176005,"twenty":5.887283,"median":14.071576,"eighty":29.782104,"marketCap":83911174294},{"date":"2021-01-29","current":64.851299,"twenty":5.887283,"median":14.109654,"eighty":29.979206,"marketCap":82231446574},{"date":"2021-02-05","current":697.695423,"twenty":5.887283,"median":14.148779,"eighty":30.122962,"marketCap":85816537080},{"date":"2021-02-12","current":681.695105,"twenty":5.887283,"median":14.235931,"eighty":30.220678,"marketCap":83848497886},{"date":"2021-02-19","current":656.013065,"twenty":5.887283,"median":14.27046,"eighty":30.484701,"marketCap":80689606951},{"date":"2021-02-26","current":627.274958,"twenty":5.887283,"median":14.306069,"eighty":30.569263,"marketCap":77154819778},{"date":"2021-03-05","current":660.171136,"twenty":5.886815,"median":14.351389,"eighty":30.669098,"marketCap":81201049740},{"date":"2021-03-12","current":628.90955,"twenty":5.886815,"median":14.411816,"eighty":30.847379,"marketCap":77355874683},{"date":"2021-03-19","current":658.536543,"twenty":5.886815,"median":14.446346,"eighty":30.947914,"marketCap":80999994835},{"date":"2021-03-26","current":666.505183,"twenty":5.887283,"median":14.479757,"eighty":31.062543,"marketCap":81980137497},{"date":"2021-04-01","current":680.094988,"twenty":5.887283,"median":14.515798,"eighty":31.220392,"marketCap":83651683496},{"date":"2021-04-09","current":666.480805,"twenty":5.886815,"median":14.621022,"eighty":31.471261,"marketCap":81977138959},{"date":"2021-04-16","current":684.496566,"twenty":5.886815,"median":14.653082,"eighty":31.596225,"marketCap":84193077595},{"date":"2021-04-23","current":670.268209,"twenty":5.886815,"median":14.712213,"eighty":42.207393,"marketCap":82442989695},{"date":"2021-04-30","current":265.489326,"twenty":5.886815,"median":14.778694,"eighty":42.567879,"marketCap":79912287049},{"date":"2021-05-07","current":277.252542,"twenty":5.886815,"median":14.856386,"eighty":42.894314,"marketCap":83453015165},{"date":"2021-05-14","current":285.544285,"twenty":5.886815,"median":14.904321,"eighty":43.205482,"marketCap":85948829715},{"date":"2021-05-21","current":286.46096,"twenty":5.886815,"median":15.044244,"eighty":43.463811,"marketCap":86224748912},{"date":"2021-05-28","current":275.460859,"twenty":5.886815,"median":15.158818,"eighty":43.913538,"marketCap":82913718554},{"date":"2021-06-04","current":280.960909,"twenty":5.886815,"median":15.193582,"eighty":44.006301,"marketCap":84569233733},{"date":"2021-06-11","current":286.544294,"twenty":5.886815,"median":15.256684,"eighty":44.397317,"marketCap":86249832475},{"date":"2021-06-18","current":277.544211,"twenty":5.886815,"median":15.331847,"eighty":44.793017,"marketCap":83540807637},{"date":"2021-06-25","current":282.835927,"twenty":5.886815,"median":15.396911,"eighty":44.953898,"marketCap":85133613908},{"date":"2021-07-02","current":288.752648,"twenty":5.886815,"median":15.472548,"eighty":45.316733,"marketCap":86914546903},{"date":"2021-07-09","current":284.252606,"twenty":5.886815,"median":15.579206,"eighty":45.697022,"marketCap":85560034484},{"date":"2021-07-16","current":285.960955,"twenty":5.886815,"median":15.726234,"eighty":45.841484,"marketCap":86074247532},{"date":"2021-07-23","current":287.58597,"twenty":5.886815,"median":15.752152,"eighty":47.568365,"marketCap":86563377017},{"date":"2021-07-30","current":16.591985,"twenty":5.886815,"median":15.856378,"eighty":51.009533,"marketCap":85647826956},{"date":"2021-08-06","current":16.706124,"twenty":5.886815,"median":15.9165,"eighty":51.009533,"marketCap":86237013283},{"date":"2021-08-13","current":17.284208,"twenty":5.886815,"median":16.177233,"eighty":51.009533,"marketCap":89221079750},{"date":"2021-08-20","current":17.59511,"twenty":5.886815,"median":16.446515,"eighty":51.009533,"marketCap":90825955833},{"date":"2021-08-27","current":17.313355,"twenty":5.886815,"median":16.628399,"eighty":51.009533,"marketCap":89371536883},{"date":"2021-09-03","current":17.478521,"twenty":5.886815,"median":16.94972,"eighty":51.009533,"marketCap":90224127302},{"date":"2021-09-10","current":17.242916,"twenty":5.886815,"median":16.972053,"eighty":51.009533,"marketCap":89007932145},{"date":"2021-09-17","current":17.393509,"twenty":5.886815,"median":17.123861,"eighty":51.009533,"marketCap":89785293998},{"date":"2021-09-24","current":17.291494,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":89258694033},{"date":"2021-10-01","current":16.652688,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85961175206},{"date":"2021-10-08","current":16.528813,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":85321732392},{"date":"2021-10-15","current":16.426798,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84795132427},{"date":"2021-10-22","current":16.33207,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":84306146745},{"date":"2021-10-29","current":11.012226,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":81424400000},{"date":"2021-11-05","current":11.251111,"twenty":5.886815,"median":17.235629,"eighty":51.009533,"marketCap":83190715179},{"date":"2021-11-12","current":11.447904,"twenty":5.893685,"median":17.235629,"eighty":51.009533,"marketCap":84645800064},{"date":"2021-11-19","current":11.653179,"twenty":5.897479,"median":17.235629,"eighty":51.009533,"marketCap":86163604126},{"date":"2021-11-26","current":11.921224,"twenty":5.918211,"median":17.235629,"eighty":51.009533,"marketCap":88145530090},{"date":"2021-12-03","current":11.800773,"twenty":6.026147,"median":17.235629,"eighty":51.009533,"marketCap":87254917790},{"date":"2021-12-10","current":11.917831,"twenty":6.210409,"median":17.235629,"eighty":51.009533,"marketCap":88120442420},{"date":"2021-12-17","current":12.250343,"twenty":6.275567,"median":17.235629,"eighty":51.009533,"marketCap":90579034123},{"date":"2021-12-23","current":12.296148,"twenty":6.286831,"median":17.235629,"eighty":51.009533,"marketCap":90917717674},{"date":"2021-12-31","current":12.318202,"twenty":6.311092,"median":17.235629,"eighty":51.009533,"marketCap":91080787532},{"date":"2022-01-07","current":12.089176,"twenty":6.331714,"median":17.2332,"eighty":50.998121,"marketCap":89387369777},{"date":"2022-01-14","current":12.175697,"twenty":6.376154,"median":17.2332,"eighty":50.998121,"marketCap":90027105373},{"date":"2022-01-21","current":11.622642,"twenty":6.392142,"median":17.2332,"eighty":50.998121,"marketCap":85937815092},{"date":"2022-01-28","current":11.682019,"twenty":6.427197,"median":17.2332,"eighty":50.998121,"marketCap":86376849324},{"date":"2022-02-04","current":12.876322,"twenty":6.478068,"median":17.2332,"eighty":50.998121,"marketCap":80155107055},{"date":"2022-02-11","current":12.507564,"twenty":6.506803,"median":17.2332,"eighty":50.998121,"marketCap":77859585210},{"date":"2022-02-18","current":12.302026,"twenty":6.55983,"median":17.2332,"eighty":50.998121,"marketCap":76580114018},{"date":"2022-02-25","current":12.311254,"twenty":6.578904,"median":17.2332,"eighty":50.998121,"marketCap":76637556570},{"date":"2022-03-04","current":12.46031,"twenty":6.599937,"median":17.2332,"eighty":50.998121,"marketCap":77565432746},{"date":"2022-03-11","current":11.6828,"twenty":6.635114,"median":17.2332,"eighty":50.998121,"marketCap":72725429992},{"date":"2022-03-18","current":11.968827,"twenty":6.678391,"median":17.2332,"eighty":50.998121,"marketCap":74505949140},{"date":"2022-03-25","current":11.884082,"twenty":6.698205,"median":17.2332,"eighty":50.998121,"marketCap":73978409872},{"date":"2022-04-01","current":12.037399,"twenty":8.02258,"median":17.2332,"eighty":50.998121,"marketCap":74932807962},{"date":"2022-04-08","current":12.567956,"twenty":8.716567,"median":17.2332,"eighty":50.998121,"marketCap":78235527670},{"date":"2022-04-14","current":12.471124,"twenty":8.90123,"median":17.2332,"eighty":50.998121,"marketCap":77632749929},{"date":"2022-04-22","current":12.55787,"twenty":9.141519,"median":17.2332,"eighty":50.998121,"marketCap":78172738322},{"date":"2022-04-29","current":16.504629,"twenty":9.361538,"median":17.2332,"eighty":50.998121,"marketCap":74518398265},{"date":"2022-05-06","current":16.996433,"twenty":10.809551,"median":17.239272,"eighty":50.998121,"marketCap":76738896748},{"date":"2022-05-13","current":17.327028,"twenty":11.245343,"median":17.247681,"eighty":50.998121,"marketCap":78231529751},{"date":"2022-05-20","current":17.735409,"twenty":11.419063,"median":17.289789,"eighty":50.998121,"marketCap":80075370520},{"date":"2022-05-27","current":18.002107,"twenty":11.443493,"median":17.319427,"eighty":50.998121,"marketCap":81279511430},{"date":"2022-06-03","current":17.627063,"twenty":11.598891,"median":17.34736,"eighty":50.998121,"marketCap":79586188275},{"date":"2022-06-10","current":16.874197,"twenty":11.674743,"median":17.353688,"eighty":50.998121,"marketCap":76186998831},{"date":"2022-06-17","current":16.260236,"twenty":11.693895,"median":17.353688,"eighty":50.998121,"marketCap":73414966111},{"date":"2022-06-24","current":17.524273,"twenty":11.796701,"median":17.385368,"eighty":51.009533,"marketCap":79122092299},{"date":"2022-07-01","current":17.32425,"twenty":11.863803,"median":17.393509,"eighty":51.009533,"marketCap":78218986617},{"date":"2022-07-08","current":17.457598,"twenty":11.905616,"median":17.41294,"eighty":51.009533,"marketCap":78821057072},{"date":"2022-07-15","current":17.390924,"twenty":11.935322,"median":17.41294,"eighty":51.009533,"marketCap":78520021844},{"date":"2022-07-22","current":16.890865,"twenty":11.980941,"median":17.41294,"eighty":51.009533,"marketCap":76262257638},{"date":"2022-07-29","current":16.599165,"twenty":12.028097,"median":17.41294,"eighty":51.009533,"marketCap":74945228518},{"date":"2022-08-05","current":18.52212,"twenty":12.086156,"median":17.427039,"eighty":51.009533,"marketCap":76626008538},{"date":"2022-08-12","current":19.074694,"twenty":12.171909,"median":17.456661,"eighty":51.009533,"marketCap":78912011126},{"date":"2022-08-19","current":19.795752,"twenty":12.222347,"median":17.478521,"eighty":51.009533,"marketCap":81895025523},{"date":"2022-08-26","current":18.895945,"twenty":12.254415,"median":17.529437,"eighty":51.009533,"marketCap":78172524363},{"date":"2022-09-02","current":19.335245,"twenty":12.287819,"median":17.577057,"eighty":51.009533,"marketCap":79989907085},{"date":"2022-09-09","current":19.777574,"twenty":12.303022,"median":17.627063,"eighty":51.009533,"marketCap":81819823480},{"date":"2022-09-16","current":19.874523,"twenty":12.328536,"median":17.735409,"eighty":51.009533,"marketCap":82220901046},{"date":"2022-09-23","current":19.044398,"twenty":12.37249,"median":17.877092,"eighty":51.009533,"marketCap":78786674386},{"date":"2022-09-30","current":18.689929,"twenty":12.440381,"median":18.002107,"eighty":51.009533,"marketCap":77320234535},{"date":"2022-10-07","current":19.477638,"twenty":12.472434,"median":18.174606,"eighty":51.009533,"marketCap":80578989760},{"date":"2022-10-14","current":20.047213,"twenty":12.542538,"median":18.389663,"eighty":51.009533,"marketCap":82935320460},{"date":"2022-10-21","current":20.538017,"twenty":12.806741,"median":18.504662,"eighty":51.009533,"marketCap":84965775639},{"date":"2022-10-28","current":29.80037,"twenty":13.013399,"median":18.615892,"eighty":51.009533,"marketCap":99354433322},{"date":"2022-11-04","current":30.22374,"twenty":13.251735,"median":18.662662,"eighty":51.009533,"marketCap":100765950507},{"date":"2022-11-11","current":30.780513,"twenty":13.37445,"median":18.717011,"eighty":51.009533,"marketCap":102622231397},{"date":"2022-11-18","current":31.45767,"twenty":13.431735,"median":18.843409,"eighty":51.009533,"marketCap":104879870318},{"date":"2022-11-25","current":32.450832,"twenty":13.459519,"median":18.879888,"eighty":51.009533,"marketCap":108191074069},{"date":"2022-12-02","current":33.4929,"twenty":13.504605,"median":18.899024,"eighty":51.009533,"marketCap":111665329520},{"date":"2022-12-09","current":33.09413,"twenty":13.606687,"median":18.972334,"eighty":51.009533,"marketCap":110335831044},{"date":"2022-12-16","current":32.638931,"twenty":13.64752,"median":19.040589,"eighty":51.009533,"marketCap":108818195992},{"date":"2022-12-23","current":31.882773,"twenty":13.702003,"median":19.108021,"eighty":51.009533,"marketCap":106297165863},{"date":"2022-12-30","current":32.296591,"twenty":13.772637,"median":19.194795,"eighty":51.009533,"marketCap":107676834093},{"date":"2023-01-06","current":33.135512,"twenty":13.805022,"median":19.238296,"eighty":51.009533,"marketCap":110473797867},{"date":"2023-01-13","current":32.454594,"twenty":13.873802,"median":19.29283,"eighty":51.009533,"marketCap":108203616508},{"date":"2023-01-20","current":31.228189,"twenty":13.90331,"median":19.320096,"eighty":51.009533,"marketCap":104114781573},{"date":"2023-01-27","current":31.499051,"twenty":13.995449,"median":19.384392,"eighty":51.009533,"marketCap":105017837141},{"date":"2023-02-03","current":22.946755,"twenty":14.041486,"median":19.450119,"eighty":51.009533,"marketCap":105371500000},{"date":"2023-02-10","current":23.544186,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":108114900000},{"date":"2023-02-17","current":23.017361,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105695720000},{"date":"2023-02-24","current":21.905815,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":100591501721},{"date":"2023-03-03","current":22.017164,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":101102814834},{"date":"2023-03-10","current":21.59078,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99144859743},{"date":"2023-03-17","current":20.996015,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":96413699455},{"date":"2023-03-24","current":21.756377,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":99905284240},{"date":"2023-03-31","current":22.564083,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":103614267917},{"date":"2023-04-06","current":22.749012,"twenty":14.066937,"median":19.46767,"eighty":50.998121,"marketCap":104463462833},{"date":"2023-04-14","current":22.645669,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":103988912733},{"date":"2023-04-21","current":23.031845,"twenty":14.061437,"median":19.457703,"eighty":51.009533,"marketCap":105762231528},{"date":"2023-04-28","current":18.688623,"twenty":14.055938,"median":19.442338,"eighty":51.020944,"marketCap":104338581228},{"date":"2023-05-05","current":17.542922,"twenty":14.055938,"median":19.3806,"eighty":51.020944,"marketCap":97942133140},{"date":"2023-05-12","current":17.583137,"twenty":14.055938,"median":19.319381,"eighty":51.020944,"marketCap":98166656624},{"date":"2023-05-19","current":17.473662,"twenty":14.050438,"median":19.278218,"eighty":51.032356,"marketCap":97555453806},{"date":"2023-05-26","current":17.348547,"twenty":14.044939,"median":19.233751,"eighty":51.043768,"marketCap":96856936300},{"date":"2023-06-02","current":17.026822,"twenty":14.044939,"median":19.162011,"eighty":51.043768,"marketCap":95060748428},{"date":"2023-06-08","current":16.997778,"twenty":14.044939,"median":19.104641,"eighty":51.043768,"marketCap":94898592579},{"date":"2023-06-16","current":17.650163,"twenty":14.039759,"median":19.040589,"eighty":51.200274,"marketCap":98540862431},{"date":"2023-06-23","current":17.45132,"twenty":14.038033,"median":18.973525,"eighty":51.252442,"marketCap":97430718537},{"date":"2023-06-30","current":16.982138,"twenty":14.036306,"median":18.920182,"eighty":51.304611,"marketCap":94811277890},{"date":"2023-07-07","current":17.033525,"twenty":14.036306,"median":18.886384,"eighty":51.304611,"marketCap":95098169009},{"date":"2023-07-14","current":17.138532,"twenty":14.036306,"median":18.848464,"eighty":51.304611,"marketCap":95684424773},{"date":"2023-07-21","current":17.860178,"twenty":14.036306,"median":18.770739,"eighty":51.304611,"marketCap":99713373958},{"date":"2023-07-28","current":17.093848,"twenty":14.036306,"median":18.679091,"eighty":51.304611,"marketCap":95434954235},{"date":"2023-08-04","current":17.179531,"twenty":14.036306,"median":18.633127,"eighty":51.304611,"marketCap":94212548600},{"date":"2023-08-11","current":18.176723,"twenty":14.036306,"median":18.52212,"eighty":51.304611,"marketCap":99681148240},{"date":"2023-08-18","current":17.381491,"twenty":14.036306,"median":18.429012,"eighty":51.304611,"marketCap":95320098004},{"date":"2023-08-25","current":17.342866,"twenty":14.036306,"median":18.328953,"eighty":51.304611,"marketCap":95108275564},{"date":"2023-09-01","current":17.376947,"twenty":14.036306,"median":18.1949,"eighty":51.304611,"marketCap":95295177717},{"date":"2023-09-08","current":16.799836,"twenty":14.036306,"median":18.174606,"eighty":51.304611,"marketCap":92130301260},{"date":"2023-09-15","current":17.576891,"twenty":14.036306,"median":18.052169,"eighty":51.304611,"marketCap":96391670348},{"date":"2023-09-22","current":17.102024,"twenty":14.036306,"median":17.993772,"eighty":51.304611,"marketCap":93787500350},{"date":"2023-09-29","current":17.136105,"twenty":14.036306,"median":17.876807,"eighty":51.304611,"marketCap":93974402503},{"date":"2023-10-06","current":16.972515,"twenty":14.036306,"median":17.771527,"eighty":51.304611,"marketCap":93077272169},{"date":"2023-10-13","current":17.440566,"twenty":14.036306,"median":17.722305,"eighty":51.304611,"marketCap":95644061736},{"date":"2023-10-19","current":18.101744,"twenty":14.036306,"median":17.689975,"eighty":51.304611,"marketCap":99269963503},{"date":"2023-10-27","current":17.835909,"twenty":14.029482,"median":17.676863,"eighty":51.032356,"marketCap":97812126710},{"date":"2023-11-03","current":18.45619,"twenty":14.029482,"median":17.650163,"eighty":33.471833,"marketCap":101213745894},{"date":"2023-11-10","current":15.89997,"twenty":14.029482,"median":17.641227,"eighty":33.09714,"marketCap":93428221287},{"date":"2023-11-17","current":15.802424,"twenty":14.029482,"median":17.615533,"eighty":32.981271,"marketCap":92855042015},{"date":"2023-11-24","current":15.984792,"twenty":14.029482,"median":17.59511,"eighty":32.559177,"marketCap":93926638045},{"date":"2023-12-01","current":16.243501,"twenty":14.029482,"median":17.57082,"eighty":32.289819,"marketCap":95446809157},{"date":"2023-12-08","current":16.550982,"twenty":14.031188,"median":17.55419,"eighty":32.133321,"marketCap":97253569904},{"date":"2023-12-15","current":17.341951,"twenty":14.031188,"median":17.52836,"eighty":32.07012,"marketCap":101901306173},{"date":"2023-12-22","current":16.737591,"twenty":14.031188,"median":17.504184,"eighty":31.887287,"marketCap":98350086772},{"date":"2023-12-29","current":17.206235,"twenty":14.029482,"median":17.486007,"eighty":31.764,"marketCap":101103839360},{"date":"2024-01-05","current":17.914503,"twenty":14.027776,"median":17.48476,"eighty":31.6075,"marketCap":105265619289},{"date":"2024-01-12","current":18.107474,"twenty":14.027776,"median":17.48476,"eighty":31.532333,"marketCap":106399517414},{"date":"2024-01-19","current":18.321651,"twenty":14.024373,"median":17.483513,"eighty":31.465946,"marketCap":107658019728},{"date":"2024-01-26","current":17.013264,"twenty":14.027776,"median":17.475784,"eighty":31.443073,"marketCap":99969941235},{"date":"2024-02-02","current":16.574308,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":97390634513},{"date":"2024-02-09","current":16.232638,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91957891851},{"date":"2024-02-16","current":16.138057,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":91422093836},{"date":"2024-02-23","current":16.008284,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":90686929118},{"date":"2024-03-01","current":15.855313,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":89820349813},{"date":"2024-03-08","current":16.198369,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91763758214},{"date":"2024-03-15","current":16.319318,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":92448934253},{"date":"2024-03-22","current":16.073021,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":91053666683},{"date":"2024-03-28","current":16.055429,"twenty":14.029482,"median":17.457598,"eighty":31.337724,"marketCap":90954004714},{"date":"2024-04-05","current":15.309217,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":86726715023},{"date":"2024-04-12","current":15.111111,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":85604442650},{"date":"2024-04-19","current":14.563017,"twenty":14.027776,"median":17.458344,"eighty":31.344417,"marketCap":82499489086},{"date":"2024-04-26","current":167.813786,"twenty":14.029482,"median":17.45909,"eighty":31.35376,"marketCap":81389686406},{"date":"2024-05-03","current":167.968051,"twenty":14.029482,"median":17.475896,"eighty":31.454751,"marketCap":81464504564},{"date":"2024-05-10","current":165.891135,"twenty":14.029482,"median":17.490666,"eighty":31.502061,"marketCap":80457200237},{"date":"2024-05-17","current":174.305702,"twenty":14.043532,"median":17.524273,"eighty":31.57906,"marketCap":84538265441},{"date":"2024-05-24","current":169.975478,"twenty":14.043532,"median":17.54896,"eighty":31.623197,"marketCap":82438106839},{"date":"2024-05-31","current":164.60675,"twenty":14.10774,"median":17.565264,"eighty":31.836928,"marketCap":79834273632},{"date":"2024-06-07","current":164.015933,"twenty":14.265245,"median":17.579161,"eighty":32.047548,"marketCap":79547727394},{"date":"2024-06-14","current":163.27099,"twenty":14.274228,"median":17.606597,"eighty":32.082158,"marketCap":79186429964},{"date":"2024-06-21","current":175.935023,"twenty":14.272576,"median":17.621828,"eighty":32.181475,"marketCap":85328486284},{"date":"2024-06-28","current":176.808405,"twenty":14.267619,"median":17.642004,"eighty":32.289819,"marketCap":85752076375},{"date":"2024-07-05","current":171.054361,"twenty":14.267619,"median":17.658975,"eighty":32.499738,"marketCap":82961365187},{"date":"2024-07-12","current":179.736802,"twenty":14.267619,"median":17.687689,"eighty":32.981271,"marketCap":87172349033},{"date":"2024-07-15","current":179.711114,"twenty":14.267619,"median":17.696211,"eighty":33.038453,"marketCap":87159890501},{"date":"2024-08-02","current":196.485179,"twenty":14.529265,"median":17.810595,"eighty":33.095635,"marketCap":95295311956},{"date":"2024-08-09","current":89.28743,"twenty":14.761123,"median":17.860178,"eighty":33.429699,"marketCap":94108951402},{"date":"2024-08-16","current":87.810922,"twenty":15.064446,"median":17.910429,"eighty":56.284205,"marketCap":92552711301},{"date":"2024-08-23","current":89.653604,"twenty":15.441554,"median":17.994613,"eighty":57.705461,"marketCap":94494898947},{"date":"2024-08-30","current":93.846889,"twenty":15.739388,"median":18.052169,"eighty":58.207525,"marketCap":98914620835},{"date":"2024-09-06","current":93.043668,"twenty":15.813085,"median":18.107474,"eighty":58.39978,"marketCap":98068026220},{"date":"2024-09-13","current":98.229166,"twenty":15.851395,"median":18.176723,"eighty":59.168901,"marketCap":103533541455},{"date":"2024-09-20","current":99.10326,"twenty":15.88894,"median":18.219893,"eighty":59.37255,"marketCap":104454835595},{"date":"2024-09-27","current":98.087422,"twenty":15.920691,"median":18.287258,"eighty":59.81346,"marketCap":103384142406},{"date":"2024-10-04","current":99.422185,"twenty":15.979621,"median":18.356937,"eighty":60.090264,"marketCap":104790983457},{"date":"2024-10-11","current":100.012789,"twenty":16.007608,"median":18.435741,"eighty":60.321593,"marketCap":105413479498},{"date":"2024-10-18","current":103.190235,"twenty":16.047512,"median":18.510381,"eighty":60.845545,"marketCap":108762508196},{"date":"2024-10-25","current":104.867549,"twenty":16.062334,"median":18.540053,"eighty":61.800519,"marketCap":110530396951},{"date":"2024-10-31","current":104.288758,"twenty":16.062334,"median":18.540053,"eighty":63.846895,"marketCap":109920350831},{"date":"2024-11-08","current":968.122222,"twenty":16.060766,"median":18.539019,"eighty":65.503766,"marketCap":121983400000},{"date":"2024-11-15","current":911.059905,"twenty":16.060766,"median":18.539019,"eighty":67.314857,"marketCap":114793548088},{"date":"2024-11-22","current":887.816058,"twenty":16.060766,"median":18.539019,"eighty":87.499083,"marketCap":111864823324},{"date":"2024-11-29","current":915.708675,"twenty":16.060766,"median":18.539019,"eighty":88.564531,"marketCap":115379293041},{"date":"2024-12-06","current":923.720384,"twenty":16.060766,"median":18.539019,"eighty":90.934033,"marketCap":116388768385},{"date":"2024-12-13","current":913.730475,"twenty":16.060766,"median":18.539019,"eighty":93.40748,"marketCap":115130039869},{"date":"2024-12-20","current":900.971087,"twenty":16.060766,"median":18.539019,"eighty":95.961249,"marketCap":113522356914},{"date":"2024-12-27","current":933.809203,"twenty":16.060766,"median":18.539019,"eighty":98.094509,"marketCap":117659959559},{"date":"2025-01-03","current":908.784976,"twenty":16.060766,"median":18.539019,"eighty":98.88828,"marketCap":114506906941},{"date":"2025-01-10","current":881.683639,"twenty":16.059197,"median":18.537985,"eighty":99.141058,"marketCap":111092138492},{"date":"2025-01-17","current":906.510046,"twenty":16.059197,"median":18.537985,"eighty":99.880493,"marketCap":114220265794},{"date":"2025-01-24","current":919.071615,"twenty":16.059197,"median":18.537985,"eighty":100.438024,"marketCap":115803023432},{"date":"2025-01-31","current":958.93234,"twenty":16.059197,"median":18.537985,"eighty":102.332679,"marketCap":120825474836},{"date":"2025-02-07","current":969.713529,"twenty":16.09178,"median":18.615892,"eighty":104.116302,"marketCap":122183904620},{"date":"2025-02-14","current":275.113188,"twenty":16.111578,"median":18.662662,"eighty":105.609347,"marketCap":132054330207},{"date":"2025-02-21","current":285.680484,"twenty":16.147709,"median":18.689929,"eighty":162.793199,"marketCap":137126632245},{"date":"2025-02-28","current":290.769403,"twenty":16.147709,"median":18.808017,"eighty":164.216297,"marketCap":139569313325},{"date":"2025-03-07","current":301.06241,"twenty":16.143392,"median":18.87176,"eighty":165.27463,"marketCap":144509957034},{"date":"2025-03-14","current":294.083284,"twenty":16.164977,"median":18.897485,"eighty":166.913912,"marketCap":141159976127},{"date":"2025-03-21","current":274.676641,"twenty":16.17325,"median":18.953832,"eighty":167.968051,"marketCap":131844787583},{"date":"2025-03-28","current":288.401392,"twenty":16.17325,"median":19.023685,"eighty":168.716781,"marketCap":138432668251},{"date":"2025-04-04","current":291.592591,"twenty":16.17325,"median":19.104641,"eighty":171.054361,"marketCap":139964443908},{"date":"2025-04-11","current":263.079356,"twenty":16.173436,"median":19.194795,"eighty":173.515242,"marketCap":126278090686},{"date":"2025-04-17","current":272.389631,"twenty":16.173436,"median":19.238296,"eighty":174.142022,"marketCap":130747023108},{"date":"2025-04-22","current":270.961196,"twenty":16.17325,"median":19.270108,"eighty":174.419449,"marketCap":130061374150}],"updateTime":1745429569624}}}